Infection Control Global Market Report 2024

The infection control market has grown strongly in recent years. It will grow from $119.1 billion in 2023 to $126.25 billion in 2024 at a compound annual growth rate (CAGR) of 6.0%. The expansion observed in the historical period can be attributed to factors such as healthcare-associated infections (HAIs), stringent regulatory standards, a growing awareness of infectious diseases, globalization and travel, and increased healthcare expenditure.

The infection control market is expected to see strong growth in the next few years. It will grow to $164.6 billion in 2028 at a compound annual growth rate (CAGR) of 6.9%. The anticipated growth in the forecast period can be attributed to pandemic preparedness, the expansion of healthcare infrastructure, the rising challenge of antimicrobial resistance, changes in the regulatory landscape, and increased public health initiatives. Key trends expected in the forecast period involve technological integration in healthcare, innovations in infection control products, advancements in disinfection technologies, a heightened emphasis on hand hygiene, and the development of rapid sterilization techniques.

The growth of the infection control market is expected to be propelled by the increasing incidence of hospital-acquired infections. Hospital-acquired infections, also known as healthcare-associated infections, are contracted by patients within healthcare facilities. These infections include conditions such as bloodstream infections and urinary tract infections linked to central-line catheters. Infection control plays a crucial role in preventing the transmission of communicable diseases in healthcare settings through high-level services, hygiene, and sterilization practices. The ease of these infection control measures contributes to the market's growth. As of May 2022, the World Health Organization reported that over 24% of patients worldwide were affected by healthcare-associated infections. Additionally, estimates from the Centers for Disease Control and Prevention (CDC) in the US indicated that hospital-acquired infections accounted for around 1.7 million infections and 99,000 associated deaths annually by 2022, with a projected increase in the future. Thus, the rising incidence of hospital-acquired infections is a driving factor for the infection control market.

The growth of the infection control market is also anticipated to be boosted by the increase in surgical procedures. Surgical procedures, conducted by trained medical professionals, are crucial for treating diseases, alleviating health conditions, and repairing bodily structures. The surge in surgical procedures necessitates efficient sterilization and disinfection practices for surgical instruments, equipment, and operating rooms, driving the demand for infection control products and services. For example, in April 2022, the Aesthetic Society reported a 54% increase in surgical procedures, with plastic surgeons performing an average of 320 procedures in 2021. The average cost of a surgical procedure also rose by 6% in the same year. Hence, the increase in surgical procedures is a key driver for the growth of the infection control market.

Major companies in the infection control market are responding to market demands by developing advanced technologies, such as digital infection prevention systems. These systems are technologically driven solutions designed to monitor, analyze, and manage infection prevention measures, particularly in healthcare settings. In June 2021, Nanosonics, an Australia-based infection prevention company, introduced AuditPro, a specialized tool aimed at enhancing and standardizing compliance with infection control measures. The unique features of AuditPro cater to infection preventionists and quality managers, contributing to the broader adoption of digital infection prevention systems.

Major companies are adopting a strategic partnership approach to introduce innovative infection prevention solutions tailored for hospitals and healthcare facilities. Strategic partnerships involve leveraging each other's strengths and resources to achieve mutual benefits. In September 2021, Sodexo, a France-based food service company, partnered with Ecolab Inc., a US-based provider of water, hygiene, and infection prevention solutions. The partnership aims to introduce the Protecta Plus program, which incorporates Ecolab's Bioquell hydrogen peroxide vapor technology to help mitigate the risk of infections in healthcare settings.

In June 2021, STERIS plc., a UK-based medical device company, acquired Cantel Medical Corporation., a US-based medical device company, for an undisclosed amount. This strategic acquisition by STERIS Plc diversified its infection prevention and procedure products and services to serve a broader range of customers.

Major companies operating in the infection control market report are Belimed AG, 3M Company, Ecolab Inc., Advanced Sterilization Products Services Inc., Getinge AB, Matachana Group, Miele Group, Sotera Health Inc., Steris plc., Reckitt Benckiser Group plc., Pal International, Metrex Research LLC, Stryker Corporation, B. Braun Melsungen AG, Olympus Corporation, Fortive Corporation, Cantel Medical Corporation, MELAG Medizintechnik GmbH & Co. KG, The HUBSCRUB Company, Daniels Corporation International Pty. Ltd., TMG Health Technologies, 4M Building Solutions, Infection Control Consulting Services, Becton Dickinson and Company, Infection Control Results, Sterigenics International LLC, Bioquell Inc., Sterilmed Inc., Conmed Corporation, Johnson & Johnson.

North America was the largest region in the infection control market in 2023. Asia-Pacific is expected to be the fastest-growing region in the global infection control market report during the forecast period. The regions covered in the infection control market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the infection control market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The main types of products and services used in infection control include disinfectors, sterilization equipment, consumables and accessories, and various services. Disinfectors encompass the company's endoscope disinfector products and standard accessories as a whole. These products are distributed through methods such as direct tenders, retail sales, and third-party distributors. They find applications in various areas, including the disinfection of surgical instruments, endoscopes, ultrasound probes, and other related applications. Major end-users of infection control products and services include hospitals and clinics, medical device companies, pharmaceutical companies, the life sciences industry, the food industry, and other relevant sectors.

The infection control market research report provides infection control market statistics, including infection control industry global market size, regional shares, competitors with a infection control market share, detailed infection control market segments, market trends and opportunities, and any further data you may need to thrive in the infection control industry. This infection control market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The infection control market includes revenues earned by entities by providing services such as environmental infection control, hand hygiene services, isolation precautions, and safe injection practice services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.